Overall, the findings of this study support our hypothesis that daily BC consumption for six months potentially mitigates CVD risk in peri- and early postmenopausal women through improving dyslipidemia, inflammation, and lipid peroxidation, as shown by decreasing trends of TG, IL-1β, and TBARS following BC treatment. The gene discussed is IL1B; the disease is breast cancer.